Advanced HER2-Positive Breast Cancer: Update on Destiny-Breast03 Data
home / news-network / advanced-her2-positive-breast-cancer-update-on-destiny-breast03-data
Mark Pegram, MD, and Sara Tolaney, MD, review data from DESTINY-Breast03 trial and implications of these data for treatment of patients with HER2+ breast cancer going forward.